• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

More than 2% circulating plasma cells as a prognostic biomarker in a large cohort of patients with newly-diagnosed multiple myeloma.

作者信息

Tian Mengru, Liang Xinyue, Xu Weiling, Yi Xingcheng, Yue Tingting, Zhang Yingjie, Yu Shanshan, Yan Yurong, Hu Zhongli, Zhang Nan, Wang Jingxuan, Hu Rui, Sun Xiaoxiao, Nie Yuanyuan, Dai Yun, Jin Fengyan

机构信息

Hematology Department, Cancer Center, First Hospital of Jilin University, 71 Xinmin Street, Changchun, 130012, Jilin, China.

Laboratory of Cancer Precision Medicine, First Hospital of Jilin University, 519 Dongminzhu Street, Changchun, 130061, Jilin, China.

出版信息

Ann Hematol. 2023 Oct;102(10):2943-2945. doi: 10.1007/s00277-023-05362-8. Epub 2023 Jul 12.

DOI:10.1007/s00277-023-05362-8
PMID:37434095
Abstract
摘要

相似文献

1
More than 2% circulating plasma cells as a prognostic biomarker in a large cohort of patients with newly-diagnosed multiple myeloma.超过2%的循环浆细胞作为一大群新诊断多发性骨髓瘤患者的预后生物标志物。
Ann Hematol. 2023 Oct;102(10):2943-2945. doi: 10.1007/s00277-023-05362-8. Epub 2023 Jul 12.
2
Prognostic value of circulating clonal plasma cells in newly diagnosed multiple myeloma.新诊断多发性骨髓瘤中循环克隆浆细胞的预后价值。
Hematology. 2021 Dec;26(1):510-517. doi: 10.1080/16078454.2021.1948208.
3
Circulating Plasma Cells in Newly Diagnosed Multiple Myeloma: Prognostic and More.新诊断多发性骨髓瘤中的循环浆细胞：预后及更多意义。
J Clin Oncol. 2023 Jan 20;41(3):708-710. doi: 10.1200/JCO.22.01606. Epub 2022 Sep 30.
4
Prognostic impact of circulating plasma cells in patients with multiple myeloma: implications for plasma cell leukemia definition.循环浆细胞对多发性骨髓瘤患者的预后影响：对浆细胞白血病定义的启示
Haematologica. 2017 Jun;102(6):1099-1104. doi: 10.3324/haematol.2016.158303. Epub 2017 Mar 2.
5
Circulating Serum MicroRNA-130a as a Novel Putative Marker of Extramedullary Myeloma.循环血清微小RNA-130a作为髓外骨髓瘤的一种新型潜在标志物
PLoS One. 2015 Sep 21;10(9):e0137294. doi: 10.1371/journal.pone.0137294. eCollection 2015.
6
Circulating plasma cells in newly diagnosed symptomatic multiple myeloma as a possible prognostic marker for patients with standard-risk cytogenetics.新诊断的有症状多发性骨髓瘤患者的循环浆细胞可作为标准风险细胞遗传学患者的预后标志物。
Br J Haematol. 2015 Aug;170(4):523-31. doi: 10.1111/bjh.13484. Epub 2015 May 26.
7
[Circulating Serum MicroRNA as Diagnostic Biomarkers for Multiple Myeloma].[循环血清微小RNA作为多发性骨髓瘤的诊断生物标志物]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017 Apr;25(2):471-475. doi: 10.7534/j.issn.1009-2137.2017.02.029.
8
Serial measurements of circulating plasma cells before and after induction therapy have an independent prognostic impact in patients with multiple myeloma undergoing upfront autologous transplantation.在接受 upfront 自体移植的多发性骨髓瘤患者中，诱导治疗前后循环浆细胞的连续测量具有独立的预后影响。
Haematologica. 2017 Aug;102(8):1439-1445. doi: 10.3324/haematol.2017.166629. Epub 2017 May 4.
9
Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myeloma.通过流式细胞术检测循环浆细胞作为302例新诊断多发性骨髓瘤患者生存的预测指标。
Blood. 2005 Oct 1;106(7):2276-9. doi: 10.1182/blood-2005-05-1858. Epub 2005 Jun 16.
10
Prognostic and predictive biomarker developments in multiple myeloma.多发性骨髓瘤的预后和预测生物标志物的发展。
J Hematol Oncol. 2021 Sep 23;14(1):151. doi: 10.1186/s13045-021-01162-7.

引用本文的文献

1
Development and validation of a prognostic staging system for primary plasma cell leukemia.原发性浆细胞白血病预后分期系统的开发与验证
J Hematol Oncol. 2025 Jul 15;18(1):72. doi: 10.1186/s13045-025-01723-0.

本文引用的文献

1
More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia-Like Multiple Myeloma.循环肿瘤血浆细胞超过 2%定义为浆细胞白血病样多发性骨髓瘤。
J Clin Oncol. 2023 Mar 1;41(7):1383-1392. doi: 10.1200/JCO.22.01226. Epub 2022 Oct 31.
2
Circulating Tumor Cell Burden as a Component of Staging in Multiple Myeloma: Ready for Prime Time?循环肿瘤细胞负荷作为多发性骨髓瘤分期的一个组成部分：准备好进入黄金时代了吗？
J Clin Oncol. 2022 Sep 20;40(27):3099-3102. doi: 10.1200/JCO.22.01040. Epub 2022 Jun 27.
3
High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma.
高循环肿瘤血浆细胞水平是新诊断多发性骨髓瘤移植候选患者侵袭性疾病的关键特征。
J Clin Oncol. 2022 Sep 20;40(27):3120-3131. doi: 10.1200/JCO.21.01393. Epub 2022 Jun 6.
4
Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma.循环肿瘤细胞在新诊断的适合移植的多发性骨髓瘤患者分期中的应用。
J Clin Oncol. 2022 Sep 20;40(27):3151-3161. doi: 10.1200/JCO.21.01365. Epub 2022 Jun 6.
5
Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage.原发性浆细胞白血病：国际骨髓瘤工作组根据外周血浆细胞百分比的共识定义。
Blood Cancer J. 2021 Dec 2;11(12):192. doi: 10.1038/s41408-021-00587-0.
6
A clinical perspective on plasma cell leukemia; current status and future directions.浆细胞白血病的临床视角：现状与未来方向
Blood Cancer J. 2021 Feb 4;11(2):23. doi: 10.1038/s41408-021-00414-6.
7
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group.多发性骨髓瘤修订国际分期系统：国际骨髓瘤工作组报告
J Clin Oncol. 2015 Sep 10;33(26):2863-9. doi: 10.1200/JCO.2015.61.2267. Epub 2015 Aug 3.
8
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.国际骨髓瘤工作组更新了多发性骨髓瘤的诊断标准。
Lancet Oncol. 2014 Nov;15(12):e538-48. doi: 10.1016/S1470-2045(14)70442-5. Epub 2014 Oct 26.
9
Multiple myeloma patients with low proportion of circulating plasma cells had similar survival with primary plasma cell leukemia patients.循环浆细胞比例低的多发性骨髓瘤患者与原发性浆细胞白血病患者的生存率相似。
Ann Hematol. 2015 Feb;94(2):257-64. doi: 10.1007/s00277-014-2211-0. Epub 2014 Sep 18.
10
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group.浆细胞白血病：国际骨髓瘤工作组关于诊断要求、反应标准和治疗建议的共识声明。
Leukemia. 2013 Apr;27(4):780-91. doi: 10.1038/leu.2012.336. Epub 2012 Nov 21.